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Isolation of pluripotent embryonic stem cells from
reprogrammed adult mouse somatic cell nuclei
Megan J. Munsie*, Anna E. Michalska*, Carmel M. O’Brien*,
Alan O. Trounson*, Martin F. Pera* and Peter S. Mountford*†
Pluripotent human stem cells isolated from early
embryos represent a potentially unlimited source of
many different cell types for cell-based gene and tissue
therapies [1–3]. Nevertheless, if the full potential of
cell lines derived from donor embryos is to be realised,
the problem of donor–recipient tissue matching needs
to be overcome. One approach, which avoids the
problem of transplant rejection, would be to establish
stem cell lines from the patient’s own cells through
therapeutic cloning [3,4]. Recent studies have shown
that it is possible to transfer the nucleus from an adult
somatic cell to an unfertilised oocyte that is devoid of
maternal chromosomes, and achieve embryonic
development under the control of the transferred
nucleus [5–7]. Stem cells isolated from such a cloned
embryo would be genetically identical to the patient
and pose no risk of immune rejection. Here, we report
the isolation of pluripotent murine stem cells from
reprogrammed adult somatic cell nuclei. Embryos were
generated by direct injection of mechanically isolated
cumulus cell nuclei into mature oocytes. Embryonic
stem (ES) cells isolated from cumulus-cell-derived
blastocysts displayed the characteristic morphology
and marker expression of conventional ES cells and
underwent extensive differentiation into all three
embryonic germ layers (endoderm, mesoderm and
ectoderm) in tumours and in chimaeric foetuses and
pups. The ES cells were also shown to differentiate
readily into neurons and muscle in culture. This study
shows that pluripotent stem cells can be derived
from nuclei of terminally differentiated adult somatic
cells and offers a model system for the development
of therapies that rely on autologous, human
pluripotent stem cells.
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Results and discussion
Blastocysts were generated by substituting cumulus cell
nuclei for the genetic material of mature oocytes using a
modification of the method described previously [6]. The
cumulus cells were collected from transgenic mice
(ZIN40) that ubiquitously express a nuclear-localised lacZ
reporter gene and demonstrate distinctive blue staining
when treated with X-gal substrate [8]. As recipient
oocytes were collected from a non-transgenic strain
(B6D2F1), the presence of the lacZ transgenic marker
was used to demonstrate nuclear contribution of the
cumulus cell nuclei following transfer [9]. In 21 replicate
experiments, 39% (362/926) of manipulated oocytes sur-
vived injection and enucleation. Following strontium
activation, 75% (270/362) of the reconstructed oocytes
cleaved to the two-cell stage after 24 hours in culture.
After 96 hours in culture, 10 (3%) morphologically normal
cumulus cell (CC)-derived blastocysts formed and were
transferred into media supplemented with leukaemia
inhibitory factor (LIF) for ES cell isolation. Eight blasto-
cysts hatched and formed obvious inner cell mass out-
growths, with three displaying putative ES cell morphology
in initial passages. One cell line, which we call the
parental CC-derived ES (CC-ES) cell line, was estab-
lished and continued to display characteristic mouse
ES cell morphology when grown in the presence or
absence of a fibroblast feeder layer in media supple-
mented with LIF (Figure 1a). Four sub-lines were estab-
lished from 48 individual, mechanically isolated cells
from the CC-ES cell line.
All CC-ES cell lines examined showed typical ES cell
morphology (Figure 1a) and expressed characteristic
mouse ES cell markers, including stage-specific embry-
onic antigen-1 (SSEA-1; Figure 1b) and alkaline phos-
phatase activity (Figure 1c). Oct4 mRNA was highly
expressed in undifferentiated ES cells and downregulated
in differentiated ES cell cultures (data not shown). All
CC-ES cell lines were demonstrated to have been derived
from a reprogrammed somatic nucleus by distinctive blue
X-gal-stained nuclei (Figure 1d) and a normal female
(40,XX) karyotype (Figure 1e). In addition to the cytologi-
cal examination, the parental CC-ES cells and clonally
derived sub-lines were shown to lack a Y-chromosome-
specific PCR product (Figure 1f). No other female ES
cells have been grown in our laboratory. The rate of ES
cell derivation from CC-derived blastocysts was not statis-
tically different (p = 0.77) from routine ES cell isolation
with respect to the sample size analysed. 
Pluripotency of the parental CC-ES cell line and two of
the clonally derived sub-lines was investigated in vitro and
in vivo. All CC-ES cell lines were found to differentiate
readily into neurons and beating muscle in vitro at a
similar frequency to control ES cells. Morphological obser-
vations were confirmed by indirect immunofluorescence
in differentiated CC-ES cell cultures using neuronal- and
muscle-specific antibodies (Figure 2). When CC-ES cells
were injected into the testis capsule of immunocompro-
mised mice, all injection sites (12/12) yielded lacZ-positive
teratocarcinomas with extensive differentiation into all
three embryonic germ layers (Figure 3a–d), including
neural epithelium and stratified squamous epithelium
(ectoderm); muscle, cartilage and bone (mesoderm); and
ciliated secretory epithelium (endoderm).
Restoration of pluripotency to the somatic nucleus was
further demonstrated by somatic cell contribution in
chimaeric foetuses and pups. Four out of six midgesta-
tion (10 days post coitum; 10 dpc) foetuses contained
X-gal-positive cells. One foetus appeared to be composed
solely of CC-ES cell derivatives (data not shown). Six out
of 14 pups were identified as chimaeric by obvious coat
and eye colour (Figure 3e). Multi-lineage CC-ES cell
contribution was confirmed by lacZ genomic PCR (data
not shown) and microscopic analysis of X-gal-stained
frozen sections. All organs analysed by X-gal staining,
including cerebellum, heart, gut (Figure 3f–h), liver,
lung, kidney, skeletal muscle, thymus and spleen,
showed extensive contribution of CC-ES-derived cells.
Detailed analysis will, however, be required to exclude
cell-type-specific restrictions in the developmental poten-
tial of CC-ES cells. 
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Figure 1
Characterisation and confirmation of CC-ES
cells. Parental CC-ES cells displayed
(a) morphology that is characteristic of mouse
ES cell colonies, (b) SSEA-1 expression and
(c) alkaline phosphatase activity.
(d–f) Nuclear contribution was confirmed by
(d) distinctive X-gal-stained nuclei, (e) female
(40,XX) karyotype, and (f) the absence of
Y-chromosome-specific PCR product (lower
band) in parental CC-ES cells and four
clonally derived CC-ES cell sub-lines. Male
ZIN40 ES cells, male foetal fibroblast (mFF)
cells and no DNA (water) controls are also
shown. The PCR primers detected the mouse
Smcy gene and its X-chromosome homologue
Smcx. The scale bars represent 100 µm.
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Figure 2
(a–d) Neural and (e,f) myogenic cells derived by in vitro
differentiation of clonally derived CC-ES cells. Morphology was
confirmed by indirect immunofluorescence to the neuron-specific
proteins (b,c) neurofilament 160 and 68 kDa and (d) MAP-2a,b,
and the muscle-specific proteins (e) alpha and gamma actin and
(f) desmin. The scale bars represent 50 µm. 
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This report describes the first isolation of pluripotent stem
cells from adult somatic cell nuclei. Although ‘ES-like’
cells have been isolated from bovine nuclear transfer
embryos derived from foetal fibroblast nuclei [10], the
mouse somatic-cell-derived ES cell research described
here offers a more accessible and diversified model system
for in vitro and in vivo investigation of nuclear reprogram-
ming and developmental competence. For example, ES
cell lines may be established from different donor cell
types and evaluated for possible restrictions in pluripo-
tency using established in vitro and in vivo ES cell differ-
entiation regimes. Such analyses may help explain the
limited development of nuclear transfer blastocysts
derived from neuronal nuclei compared with cumulus and
Sertoli cell nuclei [6,11]. These studies could also be
enhanced through the use of established transgenic mouse
lines, which harbour developmentally regulated or ubiqui-
tously expressed reporter genes to monitor reprogramming
at the molecular level or visualise cellular contribution in
chimaeric embryos [9]. Similarly, mutant mouse lines with
specific gene deletions or genetic modifications could be
used as a nuclear donor source to investigate the role of
specific genes in nuclear reprogramming.
Possibly the greatest potential for combining nuclear repro-
gramming with ES cell derivation lies in the development
of autologous human pluripotent stem cells for cell-based
gene and tissue therapies. ES cells derived from somatic
cell transplantation could restore function to diseased or
damaged tissues, or be genetically altered before transplan-
tation to deliver gene therapy. Transplantation studies in
the mouse have shown that ES cell-derived cardiomy-
ocytes [12], neural precursors [13], haematopoietic precur-
sors [14] and insulin-secreting cells [15] can survive and
function in recipient animals. Nevertheless, at least two
independent and significant challenges must be met in
order to achieve this goal in human medicine: first, the
identification of a suitable donor nuclei source and the
enhancement of nuclear reprogramming efficiency for so-
called therapeutic cloning; and, second, the establishment
of robust pluripotent stem cell culture and in vitro differen-
tiation systems. The research described here provides
proof-of-principle for human therapeutic cloning in a
model system that should play a significant role in achiev-
ing at least the first of these important goals.
Supplementary material
Additional methodological detail is available at http://current-
biology.com/supmat/supmatin.htm.
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Figure 3
CC-ES cell differentiation in vivo. Histological examination
(haematoxylin and eosin staining) of parental CC-ES teratocarcinomas
show the presence of ectoderm: (a) neural epithelium and (b) stratified
squamous epithelium; mesoderm: (c) muscle and bone; and
endoderm: (d) ciliated epithelium. Extensive somatic cell contribution
of parental CC-ES cells in chimaeric pups (left and right) was
indicated by (e) coat colour and confirmed by distinctive X-gal-stained
nuclei in (f) cerebellum, (g) heart and (h) gut (counterstained with
periodic acid schiff or PAS). The scale bars represent 100 µm. 
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